Description
The U.S. Food and Drug Administration (FDA) is conducting market research to identify qualified sources capable of providing a portable hyperspectral camera for scientific research and laboratory testing. The required system should be a commercially available portable hyperspectral imaging system capable of capturing high-resolution spectral imaging data for laboratory and research applications. The system must meet certain salient characteristics, including operating over a spectral wavelength range of 400 nm to 800 nm, providing 200 or more evenly distributed spectral bands, and producing image output of at least 512 × 512 pixels.
Some key points to consider:
• The system should be capable of meeting the specified salient characteristics.
• The system should be a standalone system with an integrated display and user interface.
• The system should be capable of storing collected data on portable media for transfer to external computers.
• The system should operate using an internal rechargeable battery and utilize standard 120V, 60 Hz U.S. power for battery charging.
• The system should weigh no more than 2 kilograms and include a minimum one-year manufacturer's warranty and technical support.
• The system should be delivered within approximately six weeks after award.